Papers
4
Total Citations
95
H-Index
3
About
Dr. Delin Wang is a leading urologic surgeon and researcher whose work centers on advancing robotic-assisted surgical techniques for complex urologic cancers, particularly renal cell carcinoma and prostate cancer. His most impactful contributions include pioneering decision-making schemes for robot-assisted cavectomy versus thrombectomy in Level II inferior vena cava thrombus, a critical procedure for advanced kidney cancer, with his 2020 paper on this topic accumulating 54 citations. Dr. Wang also conducted a landmark meta-analysis comparing Retzius-sparing to conventional robot-assisted radical prostatectomy, demonstrating significant benefits for postoperative continence and sexual function—a study that has garnered 32 citations and influenced surgical practice. Further demonstrating his commitment to improving patient outcomes, he led a systematic review on peritoneal flap fixation to prevent symptomatic lymphoceles after prostatectomy with lymph node dissection. Notably, Dr. Wang has also contributed to the literature on hereditary leiomyomatosis and renal cell cancer (HLRCC), reporting a unique case of a patient who successfully underwent pregnancy after bilateral partial nephrectomies. Through these high-impact studies, Dr. Wang has established himself as a key figure in refining robotic urologic oncology, directly enhancing both surgical safety and patients’ quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4